Literature DB >> 21725872

Effects and mechanisms of actions of Chinese herbal medicines for asthma.

Min-Li Hong1, Ying Song, Xiu-Min Li.   

Abstract

Asthma is a chronic inflammatory disorder of airways that affects approximately 300 million adults and children worldwide. Most therapy currently uses bronchodilators and corticosteroids. Systemic side effects from chronic use of these drugs are concern. Chinese medicine (CM) has a long history of human use in China and other Asian countries and well received by the patients. But as one component of Western integrative medicine (WIM), it is required that CM use is supported by scientific evidence. On the other hand, there are also suggestions that Western standardized medicine should consider personalized practice. In recent years there have been an increasing studies to narrow the gap between CM, the personalized medicine and Western medicine, evidence based medicine. This communication reviews several CM studies published in the English language in details by reviewing the effects and mechanisms of actions on asthma from clinic and experimental studies.Chinese herbal medicines exhibit broad actions on multiple asthma pathologic mechanisms. These mechanisms may involve antiinflammatory and immunomodulatory effects, inhibiting airway remodeling and normalization of hypothalamus, pituitary and adrenal (HPA)-axis disturbances. However, the mechanisms of actions of Chinese herbal medicines for asthma are not fully understood. More controlled clinical studies are warranted and some anti-asthma CM may be proved to be effective when used as monotherapy or complementary asthma therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725872     DOI: 10.1007/s11655-011-0780-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  36 in total

1.  Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.

Authors:  S S Saini; D W MacGlashan; S A Sterbinsky; A Togias; D C Adelman; L M Lichtenstein; B S Bochner
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Inhibition of mite-induced immunoglobulin E synthesis, airway inflammation, and hyperreactivity by herbal medicine STA-1.

Authors:  Tung-Ti Chang; Chieh-Chen Huang; Ching-Hsiang Hsu
Journal:  Immunopharmacol Immunotoxicol       Date:  2006       Impact factor: 2.730

3.  Anti-Asthma Simplified Herbal Medicine Intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-γ, but not transforming growth factor-β dependent.

Authors:  K Srivastava; T Zhang; N Yang; H Sampson; X M Li
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

Review 4.  Worsening of asthma with systemic corticosteroids. A case report and review of literature.

Authors:  Ankur Sheth; Savio Reddymasu; Robert Jackson
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

5.  Clinical evaluation of the Chinese herbal medicine formula STA-1 in the treatment of allergic asthma.

Authors:  Tung-Ti Chang; Chieh-Chen Huang; Ching-Hsiang Hsu
Journal:  Phytother Res       Date:  2006-05       Impact factor: 5.878

6.  Effect of ligustrazine injection on levels of interleukin-4 and interferon-gamma in patients with bronchial asthma.

Authors:  Xiao-wen Che; Ying Zhang; Hui Wang; Wei Wang
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

Review 7.  Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy.

Authors:  Xiu-Min Li; Laverne Brown
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

8.  The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.

Authors:  Nikolaos G Papadopoulos; George Philip; Hilde Giezek; Molly Watkins; Steven S Smugar; Peter G Polos
Journal:  J Asthma       Date:  2009-05       Impact factor: 2.515

9.  Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.

Authors:  Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

10.  Proteomic Analysis of Anti-inflammatory Effects of a Kampo (Japanese Herbal) Medicine "Shoseiryuto (Xiao-Qing-Long-Tang)" on Airway Inflammation in a Mouse Model.

Authors:  Takayuki Nagai; Marino Nakao; Yuliko Shimizu; Yoshio Kodera; Masamichi Oh-Ishi; Tadakazu Maeda; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

View more
  4 in total

1.  Antipyretic and anti-asthmatic activities of traditional Chinese herb-pairs, Ephedra and Gypsum.

Authors:  Fen Mei; Xue-Feng Xing; Qing-Fa Tang; Fei-Long Chen; Yang Guo; Shuai Song; Xiao-Mei Tan; Jia-Bo Luo
Journal:  Chin J Integr Med       Date:  2014-11-16       Impact factor: 1.978

2.  Andrographolide as an anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway.

Authors:  Bin Yu; Cong-qi Dai; Zhen-you Jiang; En-qing Li; Chen Chen; Xian-lin Wu; Jia Chen; Qian Liu; Chang-lin Zhao; Jin-xiong He; Da-hong Ju; Xiao-yin Chen
Journal:  Chin J Integr Med       Date:  2014-06-28       Impact factor: 1.978

3.  Sanao decoction for asthma: Protocol of a systematic review.

Authors:  Guoming Chen; Yijun Chen; Ziyin Chen; Shuai Gao; Peng Zhang; Honghui Zhang; Yanfen Huang; Yingtong Lin; Li Wei
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Chuankezhi injection for asthma: Protocol of a systematic review and meta-analysis.

Authors:  Meichen Li; Wenjiang Zheng; Chaoyuan Zhang; Qian Yan; Zijing Peng; Fuqi Xie; Yu Hong; Xiaohong Liu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.